Tasimelteon is a selective agonist of melatonin MT1 and MT2 receptors used to treat circadian rhythm sleep disorders and insomnia. Laboratories require high-quality reference standards of this drug, alongside… Read more




















Tasimelteon is a selective agonist of melatonin MT1 and MT2 receptors used to treat circadian rhythm sleep disorders and insomnia. Laboratories require high-quality reference standards of this drug, alongside its corresponding impurities, metabolites, and stable isotope labelled compounds, to support rigorous analytical testing and quality control protocols. These materials are essential for accurate impurity profiling and method validation, ensuring that pharmaceutical manufacturers can detect and quantify specific degradation products, by-products, or metabolic derivatives throughout the drug development lifecycle. By utilizing standardized reference materials—including hydroxy metabolites, glucuronide conjugates, and structurally related analogues—chemists can maintain regulatory compliance and ensure the efficacy and safety of pharmaceutical products during stability testing and routine release analysis.